David Meeker - President and CEO, Rhythm Pharmaceuticals, Inc

As of March 31, 2021


What is David Meeker's Net Worth?

The current estimated net worth of Rhythm Pharmaceuticals, Inc's President and CEO, David Meeker, is estimated to be about $1.22M . David Meeker owns about 111,335 units of Rhythm Pharmaceuticals, Inc common stock. In the last 4 years at Rhythm Pharmaceuticals, Inc, David Meeker has sold an estimated value of $0 worth.

What is David Meeker's Past Insider Trading?

David Meeker's largest purchase order was 79,525 units , worth over $425K on October 10, 2017. In total, David Meeker has made about 7 transactions over 4 years of their time at Rhythm Pharmaceuticals, Inc. David Meeker usually trades in June, with the busiest year in 2021 and 2020. The most recent transaction was a purchase order of 10,000 units , worth over $201.71K on March 31, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was David Meeker's Salary in 2020?

As President and CEO of Rhythm Pharmaceuticals, Inc, David Meeker has a total base salary of $262,308 . David Meeker received compensation valued at about $13,358,867 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of stock awards of $918,500 , option awards of $12,844,897 , other earnings, plans or compensations of $207,958 , and other compensation of $43,704 .

What is David Meeker's' Mailing Address?

  • Mailing address is C/o Penwest Pharmaceuticals Co 39 Old Ridgebury Road Suite 11 Danbury CT 06810 CT

Rhythm Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David P. Meeker, M.D. 2020 $262,308 - $918,500 $12,844,897 $207,958 $43,704 $13,358,867
Keith M. Gottesdiener, M.D. 2020 $142,906 - - $2,810,726 - $495,537 $3,449,169
Keith M. Gottesdiener, M.D. 2019 $525,934 - - $4,133,768 $277,340 - $4,937,042
Hunter C. Smith 2020 $416,118 $60,000 $132,000 $1,837,630 $209,595 $7,125 $2,530,468
Hunter C. Smith 2019 $396,992 - - $1,286,061 $153,224 $86,576 $1,922,853
Murray Stewart, D.M., F.R.C.P. 2020 $451,169 $60,000 $113,000 $1,555,420 $226,600 $7,125 $2,300,314
Jennifer Chien 2020 $45,577 $100,000 $100,000 $1,517,540 $49,375 - $1,712,492
Nithya Desikan 2020 $305,510 - $105,000 $1,533,841 - $104,620 $1,943,971
Nithya Desikan 2019 $379,063 - - $1,286,061 $145,117 - $1,810,241
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1649904/000110465921055591/tm212464-1_def14a.htm

What are Rhythm Pharmaceuticals, Inc's Past Insider Trades?

Rhythm Pharmaceuticals, Inc's most recent insider trade came on March 31, 2022 by William T Roberts who sold 1,023 units worth $11.39K . In the last 5 years, insiders at Rhythm Pharmaceuticals, Inc have sold an estimated value of $75.41M and bought an estimated value of $108.59M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Todd Foley, Director,  Keith M. Gottesdiener, CEO & President,  and Hunter C Smith, Chief Financial Officer .

RHYTHM PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1